查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012367

生物可吸收支架市场：2026-2032年全球市场预测（按材料、产品类型、分解时间、应用、最终用户和分销管道划分）

Bioabsorbable Stents Market by Material, Product Type, Degradation Time, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物可吸收支架市场价值将达到 6.0756 亿美元，到 2026 年将成长至 6.4565 亿美元，到 2032 年将达到 9.5271 亿美元，复合年增长率为 6.63%。

主要市场统计数据
基准年 2025 6.0756亿美元
预计年份：2026年 6.4565亿美元
预测年份 2032 9.5271亿美元
复合年增长率 (%) 6.63%

生物可吸收支架创新的潜力与未来前景：推动介入心臟病学，实现下一代患者照护。

生物可吸收支架领域正成为介入心臟病学领域的变革性尖端技术，可望解决永久性金属植入长期存在的难题。与长期留在动脉壁内的传统支架不同，生物可吸收支架会逐渐降解，使患者无需长期承受体内异物，即可恢復血管功能。这一转变标誌着介入性心臟病学领域的模式转移，重新定义了成功的衡量标准，从单纯的血管通畅率转向恢復血管舒缩功能和最大限度减少远期併发症。

突破性的进步和颠覆性的技术，重新定义了生物可吸收支架的开发和临床应用前景。

材料科学的进步已将生物可吸收支架从概念原型转变为具有商业性可行性的产品。从早期的聚合物基质到新一代金属合金的转变，提高了径向刚度，并实现了对吸收动力学的更好控制。同时，新型表面处理和药物释放型涂层解决了新生内膜增生这一长期难题，将临时机械支撑与局部药物治疗的优势相结合。

分析2025年美国新关税对生物可吸收支架供应链和市场动态的广泛影响。

2025年初，美国对镁和特殊聚合物等关键原料加征关税，对全球供应链产生了连锁反应。进口关税推高了关键合金和单体的单价，立即给製造商带来压力。儘管这些关税旨在保护国内生产，但却意外地促使企业迅速重新评估筹资策略和原料采购模式。

透过按材料成分、产品类型、降解时间、临床应用和最终用户对生物可吸收支架进行分类，可以获得关键见解。

材料成分的差异已成为支架性能的决定性因素，金属和聚合物两大类构成了产品系列。在金属产品系列中，工程师利用铁基来确保可控的径向强度和可预测的耐腐蚀性能，而镁合金系统则可实现加速吸收和最大限度减少发炎反应。锌合金则提供了一种折衷方案，兼具可控的使用寿命和机械柔软性。在聚合物支架设计中，聚左旋乳酸）支架已成为公认的标竿。聚己内酯（PCL）、聚二氧杂环己酮（氧环己酮聚合体）和聚乙醇酸）的同步创新提供了不同的降解週期和动态性能，可根据特定的病变形态进行客製化。

探索美洲、欧洲、中东和非洲以及亚太地区采用生物可吸收支架的独特区域趋势和成长要素。

在美洲，完善的临床基础设施和优惠的报销机制正在加速生物可吸收支架技术的早期应用。美国仍然是创新和临床试验的主要中心，而由于心血管疾病盛行率的上升和医疗服务可近性的改善，一些拉丁美洲市场对该技术的兴趣也日益浓厚。前沿研究和不断扩大的患者群体这双重动力进一步提升了该地区的战略重要性。

揭示推动生物可吸收支架製造商发展的关键竞争策略、研发合作伙伴关係和创新产品平臺。

领先的医疗设备研发公司正在加大对特种合金的研究力度，并投资下一代聚合物工程。跨国支架製造商与先进材料公司之间的合作，促成了独特配方的开发，这些配方既能优化径向支撑，又能控制分解速率。同时，越来越多的公司正与学术机构达成合作协议，透过体外试验和动物模型检验新型支架平台。

透过策略创新，为产业领导者提供可操作的蓝图，以加速生物可吸收支架的商业性成功和临床应用。

为了充分利用不断变化的临床和监管环境，行业相关人员应优先发展先进材料研发项目，以平衡机械完整性和可预测的生物利用度。策略性地专注于下一代合金和聚合物连接剂，将有助于产品差异化，并解决性能权衡这一长期存在的难题。

调查方法的详细内容包括专家访谈、二手资料以及定性和定量分析：提供高度可靠的见解。

我们的分析利用对介入性心臟病专家、材料科学家和供应链高管的深入访谈，以获取关于生物可吸收支架的真实世界观点。除了这些主要访谈之外，我们还对监管文件、临床试验註册资讯、专利申请和同行评审文献进行了详细审查。

本报告整合了关键发现和策略挑战，以确定生物可吸收支架在创新、临床部署和市场成熟方面的未来路径。

生物可吸收支架的发展历程体现了材料技术创新、血管修復治疗的临床需求以及产业内部策略合作的整合。金属和聚合物科学的进步提升了支架的性能，而精湛的製造工艺则实现了精确的形状设计，并可根据特定需求定製药物释放型功能。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生物可吸收支架市场：依材料分类

  • 金属基生物可吸收支架
    • 铁基
    • 镁基
    • 锌合金
  • 以聚合物为基础的生物可吸收支架
    • 聚左旋乳酸（PLLA）
    • 聚己内酯（PCL）
    • 氧环己酮聚合体（PDO）
    • 聚乙醇酸（PGA）

第九章：生物可吸收支架市场：依产品类型划分

  • 药物释放型型
  • 非药物释放型型

第十章：生物可吸收支架市场依时期细分

  • 12-24个月
  • 12个月以下
  • 超过24个月

第十一章：生物可吸收支架市场：依应用领域划分

  • 冠状动脉疾病（CAD）
  • 神经血管疾病
  • 适合儿童
  • 周边动脉疾病（PAD）

第十二章：生物可吸收支架市场：依最终用户划分

  • 学术和研究机构
  • 门诊手术中心
  • 心臟中心
  • 医院

第十三章：生物可吸收支架市场：依通路划分

  • 离线
  • 在线的

第十四章：生物可吸收支架市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：生物可吸收支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：生物可吸收支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国生物可吸收支架市场

第十八章：中国生物可吸收支架市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Arterius Ltd
  • B. Braun SE
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • ELLA-CS, sro
  • JW Medical Systems Ltd. Biosensors International Group, Ltd.
  • Kaneka Corporation
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • Meril Life Sciences
  • Microport Scientific Corporation
  • OrbusNeich Medical Group Holdings Limited
  • Q3 Medical Group
  • Reva Medical
  • SafeGuard Surgical, Inc.
  • Shandong Hua'an Biotechnology
  • Sino Medical Sciences Technology Inc.
  • Svelte Medical Systems Inc
  • Terumo Corporation
  • WEGO HEALTHCARE（SHENZHEN）CO., LTD
  • Zorion Medical Inc.
Product Code: MRR-4311778F8FFC

The Bioabsorbable Stents Market was valued at USD 607.56 million in 2025 and is projected to grow to USD 645.65 million in 2026, with a CAGR of 6.63%, reaching USD 952.71 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 607.56 million
Estimated Year [2026] USD 645.65 million
Forecast Year [2032] USD 952.71 million
CAGR (%) 6.63%

Uncovering the Promise and Potential of Bioabsorbable Stent Innovations Driving Cardiovascular Intervention Toward Next-Generation Patient Care

The field of bioabsorbable stents has emerged as a transformative frontier within cardiovascular intervention, promising to resolve long-standing limitations of permanent metallic implants. Unlike traditional stents that remain lodged within the arterial wall, bioabsorbable designs enable gradual degradation, offering patients the prospect of restored vessel function without long-term foreign body presence. This transition represents a paradigm shift in interventional cardiology, redefining success metrics from mere patency rates to the restoration of natural vasomotion and minimized late-stage complications.

Historically, the adoption of bioabsorbable scaffold technology has been tempered by material challenges, including mechanical strength, controlled degradation, and biocompatibility. However, continuous improvements in alloy processing, polymer chemistry, and analytical imaging have unlocked renewed confidence among clinicians and device makers. Today's research landscape is characterized by interdisciplinary collaborations that refine scaffold architecture down to the microscopic level, ensuring reliable radial support through the critical healing window before resorption commences.

This executive summary distills key observations from recent clinical outcomes, supply chain analyses, and competitive positioning. By tracing the evolution of scaffold design, evaluating emerging regulatory dynamics, and highlighting pivotal industry maneuvers, this introduction sets the stage for an in-depth exploration of the factors shaping the next generation of bioabsorbable stents.

Revolutionary Advances and Disruptive Technologies Redefining the Landscape of Bioabsorbable Stent Development and Clinical Implementation

Advances in material science have propelled bioabsorbable stents from conceptual prototypes to commercially viable options. The transition from early polymer matrices to next-generation metal alloys has enhanced radial force and controlled resorption kinetics. At the same time, novel surface treatments and drug-eluting coatings have addressed the perennial challenge of neointimal hyperplasia, marrying the benefits of transient mechanical support with localized pharmacotherapy.

Manufacturing innovations have also played a critical role in redefining the landscape. Precision laser cutting and additive manufacturing techniques enable intricate scaffold geometries that optimize fluid dynamics and endothelialization. Concurrently, bioresorbable polymer blends now incorporate specialized linkers that modulate degradation rates, ensuring structural integrity throughout the vascular remodeling phase.

Clinically, these technological advances have intersected with enhanced procedural guidance systems. High-definition intravascular imaging and computational fluid modeling facilitate personalized stent selection and deployment, reducing the incidence of malapposition and scaffold recoil. Collectively, these transformative shifts mark a new era in which bioabsorbable stents no longer represent an aspirational concept but a practical therapeutic option under broader clinical consideration.

Analyzing the Far-Reaching Consequences of Newly Imposed United States Tariffs on Bioabsorbable Stent Supply Chains and Market Dynamics in 2025

Early in 2025 the introduction of new United States tariffs on key raw materials including magnesium and specialty polymers reverberated across global supply chains. Manufacturers faced immediate cost pressures as import duties raised the unit cost of critical alloys and monomers. Although these levies aimed to protect domestic production, they inadvertently fueled a rapid reassessment of sourcing strategies and material procurement models.

As tariffs took effect, device developers evaluated the cumulative impact on production economics and pricing models. The heightened input costs necessitated a shift toward localized alloy fabrication and intensified collaboration with domestic polymer suppliers. In some cases, organizations accelerated long-term commitments with regional foundries to secure favorable pricing and reduce exposure to import duty fluctuations.

Moreover, these policy changes spurred a wave of strategic integration. Several stent providers began exploring in-house polymer synthesis capabilities and joint ventures with alloy foundries. Such vertical alignment not only offset regulatory cost burdens but also enabled tighter control over material specifications and quality assurance. Ultimately the evolving tariff environment affirmed the critical importance of supply chain resilience in sustaining bioabsorbable stent innovation.

Illuminating Critical Insights from Segmenting Bioabsorbable Stents by Material Composition Product Type Degradation Time Clinical Application and End User

Distinct material compositions have emerged as defining factors in scaffold performance, with metal-based and polymer-based categories shaping product portfolios. In the metal-based cohort engineers leverage iron-based alloys for managed radial strength and predictable corrosion profiles while magnesium-based systems deliver accelerated resorption and minimal inflammation. Zinc-based blends strike an intermediate balance, offering controlled service life and mechanical flexibility. For polymer-based designs, poly-L-lactic acid scaffolds represent the established benchmark. Concurrent innovations in polycaprolactone, polydioxanone, and polyglycolic acid provide varied degradation windows and tailored biomechanical properties for specialized lesion morphologies.

Beyond material differentiation, the distinction between drug-eluting and non-drug-eluting stents continues to influence clinical utility. Drug-eluting variants incorporate antiproliferative agents that mitigate neointimal hyperplasia, improving long-term vessel patency. Non-drug-eluting scaffolds offer simplicity and cost advantages in low-risk patients or small-vessel applications where minimal pharmacotherapy suffices.

Degradation kinetics also inform product positioning. Scaffolds engineered to dissolve within less than twelve months accommodate rapid vessel healing, while options designed for twelve to twenty-four months support more complex lesions requiring extended scaffolding. Systems with resorption profiles exceeding two years maintain mechanical integrity for protracted intervals, addressing chronic occlusions and high-stress vascular segments.

Clinical applications span from coronary artery disease management to neurovascular interventions, pediatric congenital anomalies, and peripheral arterial disease treatments. This breadth underscores the technology's versatility but also demands tailored scaffold characteristics for each anatomical context.

Diverse end-user settings further shape adoption patterns. Academic and research institutions drive early-phase evaluations and protocol development, ambulatory surgical centers optimize procedural efficiency, high-volume cardiac centers focus on outcome standardization, and hospitals integrate bioabsorbable scaffolds into multidisciplinary care pathways.

Finally the distribution landscape continues to evolve, with traditional hospital procurement complemented by emerging digital platforms that streamline access and support remote training. This dual-channel model enhances reach while preserving critical in-person service and education components.

Exploring Distinct Regional Dynamics and Growth Drivers Shaping Adoption of Bioabsorbable Stents Across Americas Europe Middle East Africa and Asia Pacific

In the Americas, robust clinical infrastructure and favorable reimbursement frameworks have fostered early uptake of bioabsorbable scaffold technology. The United States remains the primary innovation and trial hub, while select Latin American markets demonstrate growing interest fueled by rising cardiovascular disease prevalence and improving healthcare access. This dual dynamic of high-end research and expanding patient outreach reinforces the region's strategic importance.

Europe, the Middle East, and Africa exhibit considerable heterogeneity shaped by diverse regulatory regimes and health technology assessment processes. Western European nations combine rigorous clinical evidence requirements with streamlined European Union pathways, creating a balanced environment for scaffold introduction. Conversely, markets in the Gulf Cooperation Council and sub-Saharan Africa reflect uneven adoption driven by infrastructure variability and prioritization of acute care spending. Nevertheless, regional initiatives to bolster cardiovascular services and collaborative procurement consortia are gradually nurturing a more receptive ecosystem.

Asia-Pacific stands out for its unparalleled patient volumes and rapid hospital modernization efforts. In China and India, government incentives for indigenously developed medical technologies have accelerated local polymer and alloy development. Japan and South Korea complement this momentum with strong clinical trial infrastructure and regulatory alignment to global standards. Across Southeast Asia and Oceania, growing disease burden and expanding cardiac intervention programs signal an expanding addressable base for bioabsorbable stent solutions.

Unveiling the Leading Competitive Strategies R&D Collaborations and Innovative Product Pipelines Driving Bioabsorbable Stent Manufacturers Forward

Leading device developers are intensifying investments in specialized alloy research and next-generation polymer engineering. Partnerships between multinational stent manufacturers and advanced materials firms have yielded proprietary formulations that optimize radial support while controlling degradation rates. Concurrently, a growing number of companies are inking collaborative agreements with academic institutions to validate new scaffold platforms in bench and animal models.

Recent consortiums and research alliances have also accelerated the integration of drug-release technologies. By combining expertise in pharmacology, polymer science, and surface fabrication, these partnerships aim to extend the therapeutic window of antiproliferative medications and enhance endothelial recovery. Such collective endeavors reflect a trend toward shared innovation ecosystems rather than isolated R&D silos.

Beyond laboratory alliances, a series of mergers and acquisitions have reshaped competitive trajectories. Established cardiovascular device firms have acquired startups with differentiated bioresorbable offerings to augment their product suites and accelerate clinical market entry. These consolidation moves underscore the sector's emphasis on scale, regulatory expertise, and comprehensive distribution capabilities.

Additionally, several leading stent providers have inaugurated innovation funds and incubators dedicated to early-stage scaffold concepts. By nurturing startup ecosystems and providing co-development resources, they aim to replenish their pipelines with disruptive ideas and retain first-mover advantages.

Empowering Industry Leaders with Actionable Roadmaps to Accelerate Commercial Success and Clinical Adoption of Bioabsorbable Stents Through Strategic Innovation

To capitalize on evolving clinical and regulatory landscapes, industry participants should prioritize advanced material development programs that balance mechanical integrity with predictable bioresorption. Strategic focus on next-generation alloys and polymer linkers will differentiate offerings and address persistent performance trade-offs.

Stakeholders must also bolster supply chain resilience by diversifying vendor relationships and exploring regional manufacturing hubs for critical feedstocks. Vertical integration models and long-term offtake agreements can mitigate the impact of tariff fluctuations and ensure uninterrupted production capacity.

Engaging closely with key opinion leaders and trial institutions will be essential for building compelling clinical evidence. Early demonstration of favorable safety and efficacy profiles through investigator-initiated studies can streamline regulatory interactions and strengthen reimbursement dossiers.

Finally, expanding digital distribution channels alongside traditional hospital networks will enhance reach and facilitate remote training programs. Innovative e-platforms that combine product ordering with interactive physician education will support adoption in both mature and emerging markets.

Detailing a Research Methodology That Combines Expert Interviews Secondary Data and Qualitative Quantitative Analysis to Deliver Insight Credibility

Our analysis draws on in-depth interviews with interventional cardiologists, materials scientists, and supply chain executives to capture real-world perspectives on bioabsorbable stents. These primary conversations were complemented by detailed reviews of regulatory documents, clinical trial registries, patent filings, and peer-reviewed literature.

Secondary research encompassed government healthcare reports, industry white papers, and conference proceedings to ensure an extensive contextual foundation. Data from cardiology societies and professional associations provided additional validation of procedural volumes and clinical preferences.

Qualitative insights were systematically translated into quantitative metrics through structured expert panels and weighted scoring models. This combined approach enabled robust cross-validation of findings and identification of high-impact trends.

Throughout the research process, methodological rigor was maintained via peer review and iterative feedback loops with domain specialists. Quality assurance protocols ensured that all data sources met predefined reliability and relevance criteria.

Synthesizing Key Findings and Strategic Imperatives to Illuminate the Path Forward for Bioabsorbable Stent Innovation Clinical Adoption and Market Maturation

The evolution of bioabsorbable stents reflects a convergence of material innovations, clinical demand for restorative vessel therapies, and strategic industry collaboration. Advances in metal and polymer science have enhanced scaffold performance, while refinements in manufacturing enable precise geometries and tailored drug-eluting capabilities.

Segment-specific insights reveal that performance profiles vary widely across material types, degradation windows, clinical indications, end-user settings, and distribution pathways. Regional analyses highlight distinct adoption patterns in the Americas, Europe Middle East & Africa, and Asia-Pacific, each driven by local healthcare infrastructure, regulatory priorities, and reimbursement models.

Competitive dynamics center on strategic partnerships, R&D alliances, and targeted acquisitions that expand pipelines and accelerate time-to-market. To sustain momentum, industry leaders must invest in resilient supply chains, cultivate clinical evidence, and embrace digital engagement strategies.

Taken together these findings illuminate a clear strategic path for organizations seeking to lead in the bioabsorbable stent arena. Executing on these imperatives will drive both near-term impact and long-term growth as the field advances toward standard of care adoption and broader patient benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioabsorbable Stents Market, by Material

  • 8.1. Metal-based Bioabsorbable Stents
    • 8.1.1. Iron-based
    • 8.1.2. Magnesium-based
    • 8.1.3. Zinc-based Alloys
  • 8.2. Polymer-based Bioabsorbable Stents
    • 8.2.1. Poly-L-lactic acid (PLLA)
    • 8.2.2. Polycaprolactone (PCL)
    • 8.2.3. Polydioxanone (PDO)
    • 8.2.4. Polyglycolic acid (PGA)

9. Bioabsorbable Stents Market, by Product Type

  • 9.1. Drug-Eluting
  • 9.2. Non-Drug-Eluting

10. Bioabsorbable Stents Market, by Degradation Time

  • 10.1. 12-24 months
  • 10.2. Less than 12 months
  • 10.3. More 24 months

11. Bioabsorbable Stents Market, by Application

  • 11.1. Coronary Artery Disease (CAD)
  • 11.2. Neurovascular Disease
  • 11.3. Pediatric Applications
  • 11.4. Peripheral Artery Disease (PAD)

12. Bioabsorbable Stents Market, by End User

  • 12.1. Academic & Research Institutions
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Cardiac Centers
  • 12.4. Hospitals

13. Bioabsorbable Stents Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Bioabsorbable Stents Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Bioabsorbable Stents Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Bioabsorbable Stents Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Bioabsorbable Stents Market

18. China Bioabsorbable Stents Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Arterius Ltd
  • 19.7. B. Braun SE
  • 19.8. BIOTRONIK SE & Co. KG
  • 19.9. Boston Scientific Corporation
  • 19.10. Cardionovum GmbH
  • 19.11. Elixir Medical Corporation
  • 19.12. ELLA - CS, s.r.o.
  • 19.13. JW Medical Systems Ltd. Biosensors International Group, Ltd.
  • 19.14. Kaneka Corporation
  • 19.15. Kyoto Medical Planning Co. Ltd.
  • 19.16. Lepu Medical Technology Co. Ltd.
  • 19.17. Meril Life Sciences
  • 19.18. Microport Scientific Corporation
  • 19.19. OrbusNeich Medical Group Holdings Limited
  • 19.20. Q3 Medical Group
  • 19.21. Reva Medical
  • 19.22. SafeGuard Surgical, Inc.
  • 19.23. Shandong Hua'an Biotechnology
  • 19.24. Sino Medical Sciences Technology Inc.
  • 19.25. Svelte Medical Systems Inc
  • 19.26. Terumo Corporation
  • 19.27. WEGO HEALTHCARE (SHENZHEN) CO., LTD
  • 19.28. Zorion Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOABSORBABLE STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOABSORBABLE STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY IRON-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ZINC-BASED ALLOYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYCAPROLACTONE (PCL), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYDIOXANONE (PDO), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY POLYGLYCOLIC ACID (PGA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DRUG-ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NON-DRUG-ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY 12-24 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY LESS THAN 12 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY MORE 24 MONTHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE (CAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY NEUROVASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PEDIATRIC APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY CARDIAC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. GCC BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 171. GCC BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. G7 BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 195. G7 BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 196. G7 BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 198. G7 BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. G7 BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. NATO BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 205. NATO BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 207. NATO BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. NATO BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL BIOABSORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA BIOABSORBABLE STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY METAL-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY POLYMER-BASED BIOABSORBABLE STENTS, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY DEGRADATION TIME, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA BIOABSORBABLE STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)